Patient Information

Send to a friend

Text size

To view the Patient Information, you need the Adobe® Acrobat® Reader®. If you don't have the Adobe Acrobat Reader, you can download it for free.

Please choose one of the following:

I have Adobe Acrobat. Take me to the Patient Information.

I need Adobe Acrobat.

Adobe, Adobe Acrobat, and Adobe Acrobat Reader are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.


		AndroGel is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone. Safety information: AndroGel must not be used by women. You should not use AndroGel if you have any of these conditions: Prostate cancer (if your doctor knows for sure that you have it or thinks you may) Breast cancer (a rare condition for men) Warning: Elderly patients treated with androgens may be at an increased risk for the development of an enlarged prostate and prostate cancer. The most frequent adverse events reported by ≥5% of patients associated with the consistent use of AndroGel included abnormal lab test, acne, prostate disorder, and application site reaction. Remember, the information on this website does not take the place of the advice you get from your doctor or other health care professional. Always talk with your doctor if you have questions about AndroGel. Please see full Prescribing Information and Patient Information.

This information is intended for residents of the United States.
For international product information please visit us at http://www.solvay.com.
© 2007 Solvay Pharmaceuticals, Inc.